CCN2 and breast carcinoma: Atractylenolide-I, a major bioactive component from Atractylodes macrocephala, suppressed tumorigenesis of breast cancer by inhibiting TLR4-mediated NF-κB signaling pathway [31] and sensitized TNBC cells to paclitaxel by blocking connective tissue growth factor expression [32].